Pyrotech Therapeutics
PrivateLast Round
Early Funding
Jul 3, 2026
Total Funding Raised
$97M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Pyrotech Therapeutics is a biotechnology company that develops innovative drugs for the treatment of inflammation and tumors by targeting pyroptosis and innate immune pathways.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pyrotech Therapeutics Comparables
Compare Pyrotech Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Halia Therapeutics | 78% | |
| Ventus Therapeutics | 76% | |
| Inflammasome Therapeutics | 75% |
Pyrotech Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jul 3, 2026 | ||||
| Series A Extension | May 24, 2024 | ||||
| Series A | Jul 10, 2023 | ||||
| Angel | Jan 1, 2021 |
Pyrotech Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioTrack Capital | Series A, Angel |
| MSA Capital | Series A, Angel |
| Frees Fund | Series A, Series A Extension, Early Funding, Angel |
| SDIC Venture Capital | Series A |
| Lilly Asia Ventures | Series A, Series A Extension, Angel |
| Zhongguancun Development Group | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 3, 2026
Raised capital led by Shanghai STVC Leading Fund.
- May 24, 2024
Raised Series A Extension with participation from baheal-great-health-innovation-investment-fund, Frees Fund, and Lilly Asia Ventures.
Pyrotech Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Pyrotech Therapeutics's valuation, stock price, and market status.
Is Pyrotech Therapeutics a public or private company?
Pyrotech Therapeutics is a private company.
What is the current stock price of Pyrotech Therapeutics?
Pyrotech Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Pyrotech Therapeutics worth (valuation)?
Valuation information for Pyrotech Therapeutics is not publicly available.
Can I buy Pyrotech Therapeutics stock?
Pyrotech Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Pyrotech Therapeutics's last funding round?
Pyrotech Therapeutics's most recent funding round was Early Funding on July 3, 2026.
Who are the main investors in Pyrotech Therapeutics?
Key investors in Pyrotech Therapeutics include SDIC Venture Capital.
Will Pyrotech Therapeutics IPO soon?
No public IPO plans have been announced for Pyrotech Therapeutics.
How can I track Pyrotech Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pyrotech Therapeutics's secondary market activity and sign up for updates.